1,332 results on '"Stuart, David I."'
Search Results
2. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection
3. The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
4. Sample Preparation and Data Collection for High-Speed Fixed-Target Serial Femtosecond Crystallography
5. Accelerating Inhibitor Discovery With A Deep Generative Foundation Model: Validation for SARS-CoV-2 Drug Targets
6. Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike
7. Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
8. A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
9. Structural comparison of typical and atypical E2 pestivirus glycoproteins
10. Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
11. Cryogenic electron ptychographic single particle analysis with wide bandwidth information transfer
12. ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
13. Broadly neutralizing antibodies against COVID-19
14. CryoSIM: super-resolution 3D structured illumination cryogenic fluorescence microscopy for correlated ultrastructural imaging
15. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
16. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
17. A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
18. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
19. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
20. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
21. Towards in cellulo virus crystallography.
22. SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
23. Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
24. Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum
25. Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
26. A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
27. Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles
28. Purification of African Swine Fever Virus
29. High-speed fixed-target serial virus crystallography
30. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
31. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
32. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
33. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
34. Structure of CPV17 polyhedrin determined by the improved analysis of serial femtosecond crystallographic data.
35. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
36. Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
37. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections
38. Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
39. Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
40. The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus
41. COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance
42. Snapshots from Cryo-ET of active SARS-CoV-2 virions
43. Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1
44. Machining protein microcrystals for structure determination by electron diffraction
45. Glycogen Phosphorylase b
46. Multiple liquid crystalline geometries of highly compacted nucleic acid in a dsRNA virus
47. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2
48. High-Resolution Structure of the Catalytic Region of MICAL (Molecule Interacting with CasL), a Multidomain Flavoenzyme-Signaling Molecule
49. Hepatitis B Small Surface Antigen Particles Are Octahedral
50. Virus found in a boreal lake links ssDNA and dsDNA viruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.